文献速递免疫规划卫生政策与健康促进

澳大利亚两家免疫接种专科门诊中低张力低反应发作的复发风险

Recurrence risk of a hypotonic hyporesponsive episode in two Australian specialist immunisation clinics.
PubMed 文献 · Vaccine · 2018-09-06

该研究回顾性分析澳大利亚两家三级儿科医院报告的235例低张力低反应发作(HHE)病例,评估再接种后的复发率。结果显示HHE复发率为3%(7/235,95%CI 1-6%),中位随访年龄3.1岁时84%(186/221)的儿童按推荐疫苗完成接种。研究强调专科免疫接种门诊在支持国家免疫规划中的重要作用。

要点

  • HHE复发率为3%(7/235,95%CI 1-6%)。
  • 67%(157/235)的HHE发生于6-8周龄常规第一剂疫苗接种后。
  • 37%(86/235)的后续疫苗在医院监督下接种。

核心结论

  • 本研究强调专科免疫接种门诊通过随访和管理免疫接种后严重不良事件,对支持国家免疫规划具有重要意义。

研究设计与样本

  • 回顾性分析澳大利亚两家三级儿科医院(墨尔本皇家儿童医院2006-11年、悉尼韦斯特米德儿童医院1997-2014年)报告的HHE病例,共235例(墨尔本135例,悉尼100例)。
  • HHE置信度按Brighton Collaboration(BC)标准分级,免疫接种后30分钟内发生定义为即时性。
  • 利用澳大利亚免疫登记册(AIR)记录当前免疫接种状态。

主要发现

  • 235例HHE中,47%为女性,67%(157/235)发生于6-8周龄常规第一剂疫苗接种后。
  • 免疫接种后中位时间为120分钟(范围1分钟至14天),43%(102/235)为即时性HHE,按BC标准74%(173/235)为1级(明确)。
  • 后续疫苗在37%(86/235)的病例中于医院监督下接种,墨尔本为43%(58/135),悉尼为28%(28/100)。
  • HHE复发率为3%(7/235,95%CI 1-6%)。
  • AIR记录可获取于94%(221/235)的病例,中位年龄3.1岁时84%(186/221)的儿童按推荐疫苗完成接种。

临床怎么用

  • 专科免疫接种门诊可通过随访和管理免疫接种后严重不良事件,支持国家免疫规划的实施。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A hypotonic hyporesponsive episode (HHE) is a well-described adverse event following immunisation (AEFI) in young children. There is limited data regarding recurrence post re-vaccination. METHOD: A retrospective analysis of HHEs reported to two tertiary paediatric hospitals in Australia: The Royal Children's Hospital, Melbourne [2006-11] and the Children's Hospital Westmead, Sydney [1997-2014]. HHE definition level of confidence was allocated according to Brighton Collaboration (BC) criteria and defined immediate if within 30 min post vaccination. The Australian Immunisation Register (AIR) was utilised to document current immunisation status. RESULTS: 235 HHE cases (135 Melbourne, 100 Sydney) were identified: 47% were female and 67% (157/235) occurred following the routine dose one vaccines at 6-8 weeks of age. Median time following immunisation was 120 min (range 1 min to 14 days) An immediate HHE occurred in 43% (102/235) and by BC criteria, 74% (173/235) were level 1 (definite). Subsequent vaccines were administered under supervision in hospital in 37% overall (86/235); 43% (58/135) in Melbourne and 28% (28/100) in Sydney. HHE recurrence rate was 3% (7/235) [95% confidence interval 1-6%]. AIR records were available in 94% (221/235). At a median age of 3.1 years, 84% (186/221) were up-to-date with recommended vaccines. CONCLUSION: This study highlights the importance of specialist immunization clinics in supporting the National Immunisation Program, through follow-up and management of serious adverse events following immunization.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Crawford NW, McMinn A, Royle J, et al. Recurrence risk of a hypotonic hyporesponsive episode in two Australian specialist immunisation clinics. Vaccine. 2018. PMID: 30197281. doi:10.1016/j.vaccine.2018.08.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。